title: Protection of mice from oral Candidiasis by heat-killed enterococcus faecalis, possibly through its direct binding to Candida albicans.
abstract: To develop a new therapy against oral candidiasis, a commensal microorganism, Enterococcus faecalis was tested for its ability to modulate Candida growth in vitro and its therapeutic activities against a murine model in vivo. Addition of heat-killed E. faecalis strain EF2001 (EF2001) isolated from healthy human feces to the culture of C. albicans strain TIMM1768 inhibited adherence of the latter to a microtiter plate in a dose dependent manner and Candida cells surrounded by EF2001 were increased. To examine the protective activities of EF2001 in vivo, heat-killed EF2001 was applied orally before and after inoculation of Candida to the tongue of mice previously immunosuppressed. Two days after inoculation this inoculation, both the symptom score and CFU from swabbed-tongue were significantly reduced in the EF2001-treated animals. Histological analysis indicated that EF2001 may potentiate the accumulation of polymorphnuclear cells near a Candida-infected region. These results suggest that oral administration of EF2001 has protective activity against oral candidiasis and that the in vivo activity may be reflected by direct interaction between EF2001 and Candida cells in vitro and the potentiation of an immunostimulatory effect of EF2001.
authors.affiliation: Teikyo University Institute of Medical Mycology.
authors.forename: Sanae A
authors.initials: SA
authors.lastname: Ishijima
authors.forename: Kazumi
authors.initials: K
authors.lastname: Hayama
authors.forename: Kentaro
authors.initials: K
authors.lastname: Ninomiya
authors.forename: Masahiro
authors.initials: M
authors.lastname: Iwasa
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Yamazaki
authors.forename: Shigeru
authors.initials: S
authors.lastname: Abe
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D000898:Antibiosis; D001422:Bacterial Adhesion; D002176:Candida albicans / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D002180:Candidiasis, Oral / Q000188:drug therapy* / Q000382:microbiology* / Q000517:prevention & control; D004195:Disease Models, Animal; D013293:Enterococcus faecalis / Q000502:physiology*; D005260:Female; D006358:Hot Temperature; D006801:Humans; D008813:Mice, Inbred ICR; D019936:Probiotics / Q000494:pharmacology* / Q000627:therapeutic use*; D014059:Tongue / Q000382:microbiology
chemical_list: D000276:Adjuvants, Immunologic